Human mannose‐binding lectin inhibits human cytomegalovirus infection in human embryonic pulmonary fibroblast

$48.00 plus tax (Refund Policy)

Download / Buy Article:

Abstract:

A limited number of drugs have been used for treatment of human cytomegalovirus (HCMV), all sharing the similar antiviral mechanism of inhibiting virus replication. This study investigates the anti‐HCMV activities of mannose‐binding lectin (MBL) from blocking virus entry and inhibiting virus spread. Recombinant human MBL was produced in CHO cells and native human MBL was isolated from human serum. A HCMV neutralization test was performed by pre‐treating HCMV with each diluted MBL solution. Then the treated HCMV was inoculated onto the human embryonic pulmonary fibroblasts (HELF), which was followed by HCMVDNA detection, PP65 positivity examination and confocal imaging of the infected cells. To test the activity of MBL in inhibiting viral spreading after viral invasion, HCMV growth inhibition test was performed. The infected cells were incubated with each diluted MBL, every 24 h, the supernatant was tested for HCMVDNA. After 72 h, cells were collected for HCMVDNA and PP65 examination. Then the cytopathic effect was observed and cell viability was measured at the 5 days after infection. HCMV neutralization test revealed 10 μg/mL MBL significantly decreased the HCMV invasion in HELF and the anti‐HCMV activity can be blocked by 20 mg/mL mannan. HCMV growth inhibition test indicated that at 48 h after HCMV invasion, the HCMVDNA level in the culture supernatant with 10 μg/mL MBL was lower than the control. After 72 h, both the HCMVDNA levels and PP65 positivity in cells incubated with MBL were reduced. This is the first to report on the anti‐HCMV activities of MBL by in vitro studies.

Document Type: Research Article

DOI: http://dx.doi.org/10.1111/j.1600-0463.2012.02880.x

Publication date: August 1, 2012

Related content

Tools

Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more